Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
H. Jiang, A. Joshi, T. Gan, A. B. Janowski, C. Fujii, T. L. Bricker, T. Darling, H. H. Harastani, K. Seehra, H. Chen, S. Tahan, A. Jung, B. Febles, J. A. Blatter, S. Handley, , A. C. Boon
This study shows that the stem-loop II motif in SARS-CoV-2 is not essential for viral growth in vitro or in vivo.
Journal of Virology · Jun 29, 2023Peer-reviewedMicrobiology
B. Ying, T. L. Darling, P. Desai, C.-Y. Liang, I. P. Dmitriev, N. Soudani, T. L. Bricker, E. A. Kashentseva, H. H. Harastani, A. G. Schmidt, D. T. Curiel, A. C. M. Boon, M. S. Diamond
This paper shows a bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 in mice and hamsters through mucosal immunity, despite poor serum neutralizing antibody responses.
bioRxiv · May 4, 2023 · PreprintMicrobiology
J. B. Case, S. M. Scheaffer, T. L. Darling, T. L. Bricker, L. J. Adams, H. H. Harastani, R. Trende, S. Sanapala, D. H. Fremont, A. C. M. Boon, M. S. Diamond
This paper evaluates the pathogenicity of SARS-CoV-2 BQ.1.1 and BA.5.5 variants in multiple rodent models, finding increased virulence in transgenic mice but not in conventional mice or hamsters.
bioRxiv · Apr 28, 2023 · PreprintMicrobiology
A. B. Janowski, H. Jiang, C. Fujii, M. C. Owen, T. L. Bricker, T. L. Darling, H. H. Harastani, K. Seehra, S. Tahan, A. Jung, B. Febles, J. A. Blatter, S. A. Handley, B. A. Parikh, V. Lulla, , D. Wang
This study shows the stem-loop II motif is critical for astrovirus replication but not for SARS-CoV-2.
bioRxiv · Apr 30, 2022 · PreprintMicrobiology
I. D. Aziati, D. McFarland, A. Antia, A. Joshi, A. Aviles Gamboa, P. Lee, H. H. Harastani, D. Wang, S. A. Adalsteinsson, A. Boon
The study assesses the prevalence of Bourbon and Heartland viruses in ticks at an environmental field station, finding 3.9% and 7.6% positivity rates respectively.
bioRxiv · Mar 23, 2022Microbiology
J. Son, S. Huang, Q. Zeng, T. L. Bricker, J. B. Case, J. Zhou, R. Zang, Z. Liu, X. Chang, H. H. Harastani, L. Chen, M. F. Gomez Castro, Y. Zhao, H. P. Kohio, G. Hou, , S. Ding
The paper identifies JIB-04 as a broad-spectrum antiviral that inhibits SARS-CoV-2 replication and coronavirus pathogenesis in vitro and in vivo.
bioRxiv · Sep 24, 2020Microbiology